• 

  미림진, "WARS1 타깃 자가면역질환 치료제 개발…내년 하반기 비임상 진입" / MirimGENE "Development of WARS1-targeted autoimmune disease therapy, launch of pre-clinical trials in the second half of next year."

  August 17, 2023

  CEO Mirim Jin conducted an interview with HitNews on the topic of “MirimGENE's core pipeline status and future blueprint.""We will leap forward as a biotech that leads the development of innovative new drugs (first-in-class) that can save the lives of autoimmune disease patients around the world. Currently, the manufacturing process (CMC) stage of the lead pipeline (new drug candida...

  READ MORE >
• 

  미림진, BIO USA 2023 참가 / MirimGENE, at BIO USA 2023

  June 15, 2023

  MirimGENE attended BIO USA 2023 in Boston from June 5th to 8th and was chosen as the presenting company at BIO USA 2023.MirimGENE was also able to connect with numerous global companies such as Novartis, Merck, Pfizer and present our science and technology to them.   

  READ MORE >
• 

  미림진, 중기부 아기유니콘 선정 / MirimGENE, MSS's 'Baby Unicorn' designation

  May 30, 2023

  On Tuesday, May 30, the Ministry of SMEs and Startups selected 51 ‘Baby Giant Startups (Unicorns)’ that have a high potential to grow into global giant startups (Unicorns). MirimGENE is designated as one of the finalist for Ministry of SMEs and Startups' Baby Unicorn.  source : https://mss.go.kr/site/smba/ex/bbs/View.do?cbIdx=86&bcIdx=1042056&parentSeq=1042056&n...

  READ MORE >
• 

  미림진, KDRA 바이오 혁신기업 포스터존에 참가 / MirimGENE, Participated in the KDRA Bio innovative companies poster zone.

  May 16, 2023

  MirimGENE participated in KDRA Bio innovative companies poster zone for the promotion of bio-venture, start-ups, universities, and lab's technologies in part of "KOREA PHARM & BIO 2023", the largest domestic pharm·bio-health industry fair and introduced the excellent Rheumatoid Arthritis treatment effect of WARS1 Neutralizing antibody.    

  READ MORE >
• 

  미림진, 혁신신약 파이프라인UP 발표 / MirimGENE, Presented at the Acceleration Project in Innovative Drug Development

  April 25, 2023

   The CEO of MirimGENE, Professor Jin, gave a presentation on "Sepsis theranostic innovative drug development" at the Acceleration Project in Innovative Drug Development on April 25th. 

  READ MORE >
• 

  미림진, 2023 국가신약개발사업 R&D 워크샵 우수 포스터로 지정 / MirimGENE, Designation of an excellent poster at the 2023 KDDF R&D Workshop

  February 06, 2023

  1Mirim Jin, CEO of MirimGENE, gave a presentation on the topic of Novel antibody candidate for Rheumatoid Arthritis at the 2023 Korea Drug Development Porject Fund (KDDF) R&D Workshop held in Yeoju. Also, on this day, MirimGENE's poster was designated as an excellent poster.  

  READ MORE >